Target
Ephrin type-A receptor 3
Ligand
BDBM50302165
Substrate
n/a
Meas. Tech.
ChEMBL_599561 (CHEMBL1038371)
IC50
9000±n/a nM
Citation
 Wu, JPFleck, RBrickwood, JCapolino, ACatron, KChen, ZCywin, CEmeigh, JFoerst, MGinn, JHrapchak, MHickey, EHao, MHKashem, MLi, JLiu, WMorwick, TNelson, RMarshall, DMartin, LNemoto, PPotocki, ILiuzzi, MPeet, GWScouten, EStefany, DTurner, MWeldon, SZimmitti, CSpero, DKelly, TA The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part II. Bioorg Med Chem Lett 19:5547-51 (2009) [PubMed]  Article 
Target
Name:
Ephrin type-A receptor 3
Synonyms:
EPHA3 | EPHA3_HUMAN | ETK | ETK1 | Ephrin receptor | Ephrin type-A receptor 3 | Ephrin type-A receptor 3 (EPHA3) | HEK | TYRO4
Type:
Protein
Mol. Mass.:
110131.95
Organism:
Homo sapiens (Human)
Description:
P29320
Residue:
983
Sequence:
MDCQLSILLLLSCSVLDSFGELIPQPSNEVNLLDSKTIQGELGWISYPSHGWEEISGVDEHYTPIRTYQVCNVMDHSQNNWLRTNWVPRNSAQKIYVELKFTLRDCNSIPLVLGTCKETFNLYYMESDDDHGVKFREHQFTKIDTIAADESFTQMDLGDRILKLNTEIREVGPVNKKGFYLAFQDVGACVALVSVRVYFKKCPFTVKNLAMFPDTVPMDSQSLVEVRGSCVNNSKEEDPPRMYCSTEGEWLVPIGKCSCNAGYEERGFMCQACRPGFYKALDGNMKCAKCPPHSSTQEDGSMNCRCENNYFRADKDPPSMACTRPPSSPRNVISNINETSVILDWSWPLDTGGRKDVTFNIICKKCGWNIKQCEPCSPNVRFLPRQFGLTNTTVTVTDLLAHTNYTFEIDAVNGVSELSSPPRQFAAVSITTNQAAPSPVLTIKKDRTSRNSISLSWQEPEHPNGIILDYEVKYYEKQEQETSYTILRARGTNVTISSLKPDTIYVFQIRARTAAGYGTNSRKFEFETSPDSFSISGESSQVVMIAISAAVAIILLTVVIYVLIGRFCGYKSKHGADEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQAVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAKISTDDMKKVGVTVVGPQKKIISSIKALETQSKNGPVPV
  
Inhibitor
Name:
BDBM50302165
Synonyms:
3-amino-6-(4-hydroxypiperidin-1-yl)-4-propylthieno[2,3-b]pyridine-2-carboxamide | CHEMBL576887
Type:
Small organic molecule
Emp. Form.:
C16H22N4O2S
Mol. Mass.:
334.436
SMILES:
CCCc1cc(nc2sc(C(N)=O)c(N)c12)N1CCC(O)CC1
Structure:
Search PDB for entries with ligand similarity: